NYC Passport #81627Y0873

Roche molecular diagnostics assays, reagents, and consumables for NYC Public Health Laboratory

New York City’s Department of Health and Mental Hygiene is seeking Roche supplies for molecular testing at its Public Health Laboratory. - Government buyer: City of New York, Department of Health and Mental Hygiene (DOHMH), for the Public Health Laboratory (PHL). - OEM: Roche Diagnostic Corporation, identified as the sole manufacturer and distributor of the requested assays, reagents, and consumables for these Roche platforms. - Requested products: Supplies for cobas 5800, cobas 6800v2, and cobas 8800v2 systems; MagNA Pure 96 extraction kits; and LightCycler PCR applications, including LightCycler 96 and LightCycler PRO. - Listed tests cover hepatitis C and B, HIV, CMV, EBV, BKV, SARS-CoV-2, respiratory pathogens, HPV, chlamydia/gonorrhea (CT/NG), and trichomonas/Mycoplasma genitalium (TV/MG). The cobas 5800 list also includes HIV-1/2 Qual and the omni utility channel test. - MagNA Pure 96 kits include two DNA and Viral Nucleic Acid Kits and one Cellular RNA Kit; these are stated kit components, not a total purchase quantity. - Quantities and part numbers: No purchase quantities or individual part numbers are provided for the requested supplies. - Notable requirements: The procurement supports higher testing capacity and faster molecular test results. Only Roche-certified service engineers may perform service activities on the systems. - Period: Anticipated six-year contract term; no option years or annual subscription terms are specified.

Description

The New York City Department of Health and Mental Hygiene intends to negotiate a six-year sole-source agreement with Roche Diagnostic Corporation for assays, reagents, and consumables used with the cobas® 5800, 6800v2, and 8800v2, MagNA Pure96, and LightCycler systems. These systems support high-throughput molecular testing, nucleic acid extraction, and quantitative PCR, including testing for HIV, sexually transmitted infections, and bloodborne pathogens. The products will be used by the NYC Public Health Lab to reduce detection times for sexually transmitted infections and increase testing capacity. The agency states that Roche is the sole manufacturer and distributor of the specified products; firms that believe they can legally provide them may submit an Expression of Interest by November 2, 2026, at 2:00 PM.

View original listing